The aim of this study was to evaluate the therapeutic properties of Mimosa caesalpiniifolia in liver of rats exposed to cadmium under morphological, oxidative, inflammatory, and mutagenic parameters. A total of 40 Wistar rats (90days, ~ 250g) were distributed into eight groups (n= 5) as follows: (i) control; (ii) cadmium: cadmium chloride injection at 1.2mg/kg; (iii) Mimosa extract: treatment with Mimosa extract at 250mg/kg; (iv) Mimosa fraction: treatment with Mimosa acetate fraction at 62.5mg/kg; (v) cadmium and Mimosa extract 62.5: submitted to cadmium chloride at 1.2mg/kg injection and treatment with Mimosa extract at 62.5mg/kg; (vi) cadmium and Mimosa extract 125: subjected to cadmium chloride at 1.2mg/kg injection and treatment with Mimosa extract at 125mg/kg; (vii) cadmium and Mimosa 250 extract: submitted to cadmium chloride 1.2mg/kg injection and treatment with Mimosa extract at 250mg/kg; (viii) cadmium treated with fraction of Mimosa acetate: submitted to cadmium chloride 1.2mg/kg injection and treatment with acetate fraction of Mimosa extract at 62.5mg/kg. In the animals intoxicated with cadmium and treated with fraction [62.5], increased expression of SOD-Mn reduced frequency of binucleated hepatocytes, karyolysis, and karyorrhexis, besides the antimutagenic and antioxidant action. The extract [62.5] was cytoprotective, antimutagenic, and reduced karyolysis. The extract [125] was cytoprotective, antioxidant, antifibrotic, anti-inflammatory, and reduced frequency of binucleated hepatocytes, while extract [250] was cytotoxic and mutagenic. In summary, the extract of Mimosa exerts some therapeutic properties in hepatic tissue after Cd intoxication, but only when it is administrated at intermediate doses. Probably, a high content of polyphenols in the EHM [250] and Fr-EtOAc groups exert pro-oxidant activities in the liver particularly when associated with Cd.